Advanced glycation end product signaling and metabolic complications: Dietary approach
- PMID: 37547584
- PMCID: PMC10401445
- DOI: 10.4239/wjd.v14.i7.995
Advanced glycation end product signaling and metabolic complications: Dietary approach
Abstract
Advanced glycation end products (AGEs) are a heterogeneous collection of compounds formed during industrial processing and home cooking through a sequence of nonenzymatic glycation reactions. The modern western diet is full of heat-treated foods that contribute to AGE intake. Foods high in AGEs in the contemporary diet include processed cereal products. Due to industrialization and marketing strategies, restaurant meals are modified rather than being traditionally or conventionally cooked. Fried, grilled, baked, and boiled foods have the greatest AGE levels. Higher AGE-content foods include dry nuts, roasted walnuts, sunflower seeds, fried chicken, bacon, and beef. Animal proteins and processed plant foods contain furosine, acrylamide, heterocyclic amines, and 5-hydroxymethylfurfural. Furosine (2-furoil-methyl-lysine) is an amino acid found in cooked meat products and other processed foods. High concentrations of carboxymethyl-lysine, carboxyethyl-lysine, and methylglyoxal-O are found in heat-treated nonvegetarian foods, peanut butter, and cereal items. Increased plasma levels of AGEs, which are harmful chemicals that lead to age-related diseases and physiological aging, diabetes, and autoimmune/inflammatory rheumatic diseases such as systemic lupus erythematosus and rheumatoid arthritis. AGEs in the pathophysiology of metabolic diseases have been linked to individuals with diabetes mellitus who have peripheral nerves with high amounts of AGEs and diabetes has been linked to increased myelin glycation. Insulin resistance and hyperglycemia can impact numerous human tissues and organs, leading to long-term difficulties in a number of systems and organs, including the cardiovascular system. Plasma AGE levels are linked to all-cause mortality in individuals with diabetes who have fatal or nonfatal coronary artery disease, such as ventricular dysfunction. High levels of tissue AGEs are independently associated with cardiac systolic dysfunction in diabetic patients with heart failure compared with diabetic patients without heart failure. It is widely recognized that AGEs and oxidative stress play a key role in the cardiovascular complications of diabetes because they both influence and are impacted by oxidative stress. All chronic illnesses involve protein, lipid, or nucleic acid modifications including crosslinked and nondegradable aggregates known as AGEs. Endogenous AGE formation or dietary AGE uptake can result in additional protein modifications and stimulation of several inflammatory signaling pathways. Many of these systems, however, require additional explanation because they are not entirely obvious. This review summarizes the current evidence regarding dietary sources of AGEs and metabolism-related complications associated with AGEs.
Keywords: Advanced glycation end products; Cardiac complication; Diabetes; Food safety; Heat-treated diets; Maillard reaction products; Metabolic disorder; Receptor for advanced glycation end products.
©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Conflict of interest statement
Conflict-of-interest statement: The authors have no conflicts of interest to declare.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10401445/bin/WJD-14-995-g001.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10401445/bin/WJD-14-995-g002.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10401445/bin/WJD-14-995-g003.gif)
Similar articles
-
Estimation of Advanced Glycation End Products in Selected Foods and Beverages by Spectrofluorimetry and ELISA.Plant Foods Hum Nutr. 2024 Jun;79(2):277-284. doi: 10.1007/s11130-024-01173-y. Epub 2024 Apr 12. Plant Foods Hum Nutr. 2024. PMID: 38607509
-
Dietary intake of advanced glycation endproducts is associated with higher levels of advanced glycation endproducts in plasma and urine: The CODAM study.Clin Nutr. 2018 Jun;37(3):919-925. doi: 10.1016/j.clnu.2017.03.019. Epub 2017 Mar 23. Clin Nutr. 2018. PMID: 29381139
-
Advanced Glycation End Products, Inflammation, and Chronic Metabolic Diseases: Links in a Chain?Crit Rev Food Sci Nutr. 2016;56(6):989-98. doi: 10.1080/10408398.2012.744738. Crit Rev Food Sci Nutr. 2016. PMID: 25259686 Review.
-
Advanced glycation endproducts in food and their effects on health.Food Chem Toxicol. 2013 Oct;60:10-37. doi: 10.1016/j.fct.2013.06.052. Epub 2013 Jul 16. Food Chem Toxicol. 2013. PMID: 23867544 Review.
-
The low-AGE content of low-fat vegan diets could benefit diabetics - though concurrent taurine supplementation may be needed to minimize endogenous AGE production.Med Hypotheses. 2005;64(2):394-8. doi: 10.1016/j.mehy.2004.03.035. Med Hypotheses. 2005. PMID: 15607576
Cited by
-
Resultant compound from sublimation test for Gentianae Radix in Japanese Pharmacopoeia was 5-(hydroxymethyl)furfural.J Nat Med. 2024 Jun;78(3):799-802. doi: 10.1007/s11418-024-01802-5. Epub 2024 Mar 19. J Nat Med. 2024. PMID: 38502471
-
Ultra-processed food consumption and metabolic disease risk: an umbrella review of systematic reviews with meta-analyses of observational studies.Front Nutr. 2024 Jan 31;11:1306310. doi: 10.3389/fnut.2024.1306310. eCollection 2024. Front Nutr. 2024. PMID: 38356860 Free PMC article.
-
Green Cancer Prevention and Beyond.Cancer Prev Res (Phila). 2024 Mar 4;17(3):107-118. doi: 10.1158/1940-6207.CAPR-23-0308. Cancer Prev Res (Phila). 2024. PMID: 38251904 Free PMC article. Review.
References
-
- Monnier VM, Taniguchi N. Advanced glycation in diabetes, aging and age-related diseases: editorial and dedication. Glycoconj J. 2016;33:483–486. - PubMed
-
- Vlassara H, Striker GE. Advanced glycation endproducts in diabetes and diabetic complications. Endocrinol Metab Clin North Am. 2013;42:697–719. - PubMed
-
- Johnson EM, Christian MS, Dansky L, Gabel BE. Use of the adult developmental relationship in prescreening for developmental hazards. Teratog Carcinog Mutagen. 1987;7:273–285. - PubMed
Publication types
LinkOut - more resources
Full Text Sources